Results 211 to 220 of about 205,038 (298)

Oxidative phosphorylation at the crossroads of cancer: Metabolic orchestration, stromal collusion, and emerging therapeutic horizons

Interdisciplinary Medicine, EarlyView.
Although most cancer cells rely on aerobic glycolysis, Oxidative phosphorylation (OXPHOS) remains essential for their survival, proliferation, and metastasis. With the emergence of OXPHOS‐targeted drugs, its therapeutic potential is becoming increasingly evident.
Keke Chen, Bo Wang, Hongying Shu, Jianxin Lyu, Wei Cui, Hezhi Fang   +5 more
wiley   +1 more source

The effect of combination therapy on Bevacizumab, Carmustine, and Metformin chemotherapy drugs on the fluctuating performance expression of TLR2, TLR6, and IL-6 genes in the cell line of brain glioblastoma. [PDF]

Cancer Cell Int
Norollahi SE, Yousefi B, Yousefzadeh-Chabok S, Nejatifar F, Samadian M, Evazalipour M, Eftekhary M, Akhlaghi MF, Mirzajani E, Rashidy-Pour A, Samadani AA.   +10 more
europepmc   +1 more source

T.P.4 Treatment with oral metformin improves muscle function in mdx mice [PDF]

, 2012
Rebecca Terry, Dominic J. Wells
openalex   +1 more source

In Vitro and Clinical Evaluation of Potential Interactions of Bemnifosbuvir with Drug Transporters

The Journal of Clinical Pharmacology, EarlyView.
Abstract Bemnifosbuvir is a novel oral guanosine nucleotide prodrug candidate for the treatment of chronic hepatitis C virus infection. Potential drug–drug interactions (DDIs) of bemnifosbuvir as a substrate or perpetrator with regard to ATP‐binding cassette (ABC) and solute carrier (SLC) transporters were evaluated in vitro and in clinical studies ...
Xiao‐Jian Zhou, Alex Vo, Gaetano Morelli, Maureen Montrond, Shannan Lynch, Keith Pietropaolo, Bruce Belanger, Arantxa Horga, Nancy Agrawal, Janet Hammond   +9 more
wiley   +1 more source

Case report: Metformin-induced hemolytic anemia in a glucose-6-phosphate dehydrogenase-deficient patient. [PDF]

J Int Med Res
Salamat AM, Ammar HM, Alsagheir AI, Mushcab HS.   +3 more
europepmc   +1 more source

Metformin reverses periodontal destruction caused by experimental periodontitis by inhibiting interleukin‐1β activity

Journal of Periodontology, EarlyView.
Abstract Background Periodontitis is a destructive disease that affects periodontal tissue. While current research focuses on disease management, research on tissue repair remains limited. Metformin, a first‐line medication for diabetes treatment, has positive effects on bone health in nondiabetic patients.
Zhao Wang, Ju Han Song, Jung‐Woo Kim, Seung‐Hee Kwon, Xianyu Piao, Sin‐Hye Oh, Suk‐Gyun Park, Sun‐Hun Kim, Je‐Hwang Ryu, Ok‐Su Kim, Jeong‐Tae Koh   +10 more
wiley   +1 more source

Triple oral therapy with metformin, DPP-4 inhibitor, and SGLT2 inhibitor for adults with type 2 diabetes: Consensus recommendations of a Chinese expert panel (version 2025). [PDF]

Diabetes Obes Metab
Yu M, Wang T, Xu C, Bi Y, Gao L, Wang G, Xiang G, Xue Y, Yang T, Kang D, Zhou Z, Guo L, Xiao X, Steering Committee, Development Group, Diabetes Committee of the Chinese Research Hospital Association.   +15 more
europepmc   +1 more source

Sleep in a mouse model of fragile X syndrome is resistant to metabolic manipulations. [PDF]

Hum Mol Genet
Lopez Valencia M, Velázquez Aponte RA, Baur JA, Jongens TA, Sehgal A.   +4 more
europepmc   +1 more source

Metformin and reduced risk of cancer in diabetic patients

British medical journal, 2005
J. Evans, L. Donnelly, A. Emslie-Smith, D. Alessi, A. Morris   +4 more
semanticscholar   +1 more source

The Satiety Awakens: Metformin Restores Intestinal Lipid Sensing. [PDF]

Diabetes
López M, Nogueiras R.
europepmc   +1 more source